AX·NEWS
Sign in

Biotech & Medtech

Biotech & Medtech news today

42 stories from 4 sources in the last 48 hours, every one in English. Each links to its publisher.

Open in the live feedRSS feedOn a TV

  1. Windward prices $175M IPO to advance China-licensed lung drugs
    USBioPharma Dive

    The Swiss biotech, which pocketed another $50 million through a concurrent private share sale to Sanofi, is developing a potential competitor to the blockbuster asthma treatment Tezspire.

  2. 62 Organizations Call on Congress to Advance 4 Medicare Reforms
    USMedCity News

    The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments and protect patient access to care. The post 62 Organizations Call on Congress to Advance 4 Medicare Reforms…

  3. Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials
    USMedCity News

    Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion deal. The post Pfizer Deal With Blackstone…

  4. Is AI Really Saving Hospitals Money? A New Study Raises Questions About the Cost of AI-Driven Care
    USMedCity News

    Healthcare systems are investing in AI to streamline workflows and save money, but a new study in the New England Journal of Medicine shows that AI-generated care plans might actually cost far more than those ordered by physicians. . The…

  5. Blackstone bets $1.5B on Pfizer’s obesity drug
    USBioPharma Dive

    The deal will support a sprawling Phase 3 program for a monthly GLP-1 shot Pfizer acquired by winning a bidding war for the drug’s previous owner, Metsera.

  6. STAT+: Blackstone backs Pfizer’s bet on monthly obesity treatment
    USSTAT News

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The song “ Donnie Darko ” by Let’s Eat Grandma was on repeat during the making of this Readout. The need-to-know…

  7. Bristol Myers research chief to depart in ‘evolution’ of company’s structure
    USBioPharma Dive

    Robert Plenge is leaving as part of a shift that will see the company merge together its R&D department in a bid to speed development and capitalize on new technologies.

  8. Sustaining Effective Care Teams During Staff Shortages 
    USMedCity News

    [Sponsored] Join us on December 9 at 1 p.m. ET for an Inovalon-sponsored webinar, where panelists will discuss why hospitals and post-acute care facilities continue to struggle with staffing shortages and turnover. They will also share…

  9. STAT+: Scientists debut map of basal ganglia, a key brain region involved in an array of diseases
    USSTAT News

    A massive scientific collaboration meant to unravel the mysteries of the human brain has produced the most detailed map yet of the basal ganglia, a region closely associated with a wide array of psychiatric and neurologic disorders…

  10. STAT+: Will Heidi Overton get to run the FDA?
    USSTAT News

    You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. RFK Jr. paid tribute to the late…

  11. When the Enrollment Freeze Ends, Claim Review Takes Over — Small Providers Need Clear Rules
    USMedCity News

    A large health system absorbs an appeal as routine. For a small agency with a few office staff, every hour chasing a physician signature or a face-to-face note is an hour not spent on patients. The post When the Enrollment Freeze Ends…

  12. STAT+: New documents raise more questions about Medicare’s AI prior-authorization experiment
    USSTAT News

    Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! With…

  13. The FDA has over 1k open jobs — and the staffing shortage is hitting pharma
    USBioPharma Dive

    The agency is still recovering from a mass staff exodus last year that left it shorthanded. Here’s what it means for the industry.

  14. STAT+: Pharmalittle: We’re reading about FDA shelving fast-track review, a Canadian importer arrested, and more
    USSTAT News

    Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say “Every new day should be…

  15. Beyond Metrics: How to Repair Our Relationship With Wearables
    USMedCity News

    Users are, rightfully, upset that the devices they bought are not delivering the results they were promised. But is that indignation pointed at the right flaw? The post Beyond Metrics: How to Repair Our Relationship With Wearables appeared…

  16. Experts update prostate cancer screening guidelines for men
    USSTAT News

    Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Happy Thursday. We’ve got a great lineup for you today, including an inside look at shuffles within the Senate’s health…

  17. American Cancer Society revises guidelines, urges routine PSA screening for prostate cancer
    USSTAT News

    In a major change to screening guidelines, the American Cancer Society recommended on Thursday that American men between ages 50 and 69 at an average risk of prostate cancer should test their prostate-specific antigen (PSA) blood levels…

  18. STAT+: What to know about Biogen’s big lupus study readout
    USSTAT News

    This story first appeared in Adam’s Biotech Scorecard, a STAT newsletter. Sign up here to get it delivered to your inbox. And subscribe to STAT+ to get an unabridged version, with exclusive content. More than two years have passed since…

  19. STAT+: Alnylam, once in the hunt to be a $100 billion biotech, needs to solve its heart drug problem 
    USSTAT News

    This story first appeared in Adam’s Biotech Scorecard, a STAT newsletter. Sign up here to get it delivered to your inbox. And subscribe to STAT+ to get an unabridged version, with exclusive content. Accountability check: Let’s talk about…

  20. Newly elected doctors and scientists hope to restore trust in science. It won’t be easy
    USSTAT News

    Last week, doctors and scientists across the country persuaded Americans to vote them into office. Now comes the hard part: Convincing those who didn’t trust them to believe in their mission. Doctors and public health officials ran…

  21. Opinion: 3 things new governors must do to lead on health
    USSTAT News

    As former state health leaders, we know the challenges and opportunities facing the 21 new governors stepping into their roles on Jan. 1. Health is what lets people go to work, raise their kids, and enjoy the years they’ve earned. Health…

  22. Opinion: I research MAHA and Black Americans. The relationship is complicated — and fascinating
    USSTAT News

    When one thinks about the key supporters of MAHA, they likely don’t envision Black people, and rightfully so. A 2025 poll from KFF and The Washington Post found that only 30% of Black Americans support the MAHA movement, compared with 43%…

  23. A comprehensive analysis of CBER experience with AAV gene therapy IND submissions
    GBNature Biotechnology

    Nature Biotechnology, Published online: 12 November 2026; doi:10.1038/s41587-026-03378-9 An analysis of Investigational New Drug (IND) submissions to the US Food and Drug Administration (FDA) from 1995 to 2025 reveals a rapid growth in…

  24. Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy
    USMedCity News

    Merck KGaA drug Pimjetmi is now FDA approved for treating tenosynovial giant cell tumor. This drug complements other rare tumor assets the Germany-based drugmaker has acquired in a series of business deals. The post Drug Approval Marks…

  25. Maven Clinic’s Virtual Care Clinic Goes In Network with 475 Plans
    USMedCity News

    Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide. The post Maven Clinic’s Virtual Care Clinic Goes In Network with 475 Plans appeared first on MedCity News .

  26. All of Us study finds thousands of new genetic variants affecting drug responses
    USSTAT News

    A study of nearly 100,000 Americans identified thousands of new variants in a set of genes that influence our responses to prescription drugs, thanks to the inclusion of participants from a more diverse set of ancestries than previous…

  27. Democrats’ Midterm Wins Could Reshape Healthcare Access for Underserved Americans
    USMedCity News

    Democrats’ huge wins last week might mean big changes coming to healthcare across the country, especially in states which flipped blue. How might the shift in power affect affordability, access, and coverage? The post Democrats’ Midterm…

  28. Can an Infrastructure for Price Transparency Improve Healthcare Competition and Quality?
    USMedCity News

    [Sponsored] In an interview, Wayne Luan, senior director, life sciences and provider solutions with Turquoise Health, told MedCity News Editor-in-Chief Arundhati Parmar that the company’s platform provides pricing data for medical…

  29. STAT+: Most-favored nations policy makes drugmakers rethink launches abroad
    USSTAT News

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Thanksgiving is approaching and I’ve yet to make an all-butter pie crust that doesn’t shrink. Any…

  30. Opinion: What MAHA’s support for Russell Brand tells us about the movement
    USSTAT News

    The British comedian Russell Brand is a major figure in health secretary Robert F. Kennedy’s Make America Healthy Again movement. He regularly joined conference calls organized by the super PAC MAHA Action , on one occasion dialing in…

  31. Drug price hikes in Germany could push US costs higher, study says
    USBioPharma Dive

    The report comes amid escalating tensions between the U.S. and Germany over drug prices, with several large pharmaceutical companies responding by scaling back investments in the country.

  32. STAT+: BMI alternative would flip obesity diagnosis for millions, study finds
    USSTAT News

    LONDON — Millions of people would have their obesity diagnoses flipped — from having obesity to not, and vice versa — if an alternate way of defining the disease supplanted the standard body mass index measure, according to a new study…

  33. STAT+: Why this former ER doc thinks giving AI less information is sometimes better
    USSTAT News

    This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. Let me know if, especially after reading the below item…

  34. STAT+: Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDA
    USSTAT News

    WASHINGTON — The Senate health committee has scheduled a pivotal vote for next week on the nomination of Heidi Overton to serve as commissioner of the Food and Drug Administration — despite lingering doubts from Republicans on the panel…

  35. STAT+: Pharmalittle: We’re reading about Dems eyeing Trump MFN deals, fewer drug launches in Europe, and more
    USSTAT News

    Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While…

  36. Follow the Leader: How to Build and Retain Great Clinical Teams
    USMedCity News

    We spend more than a decade training physicians and teach them almost nothing about leading people. So, what do we do? We take the best clinician in the group, hand them the title, and assume that leadership comes with it. The post Follow…

  37. AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning
    USBioPharma Dive

    The deal gives AstraZeneca a simpler way to make conjugate vaccines. Elsewhere, a psychedelic depression drug was submitted to the FDA and an autoimmune disease-focused biotech’s shares collapsed.

  38. The U.S. may soon lose measles elimination status
    USSTAT News

    Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Good morning. We’re working today here at STAT. Send story ideas (I’m still on the addiction beat!), your favorite workday…

  39. Opinion: Low-income parents can’t afford to take chances with nutritious food their picky eaters might reject
    USSTAT News

    As high food costs and cuts to food assistance squeeze families’ budgets, concerns are growing about whether low-income parents will be able to keep putting food on the table. But these financial pressures threaten to do more than increase…

  40. STAT+: Doctors on Kennedy’s influential preventive care panel have major conflicts of interest, filings reveal
    USSTAT News

    WASHINGTON — Federal officials have granted blanket waivers to every member of an influential, yet little-known federal panel that evaluates preventive medical services, allowing them to serve despite some having clear financial stakes in…

  41. A new tactic in the war over out-of-network bills: Health care providers are suing employers
    USSTAT News

    This past August, Joe Hancock, a Kentucky plumbing and heating contractor, opened a just-delivered box packed with hundreds of sheets of paper. Leafing through them, he read seven words no small business owner wants to see: “A lawsuit has…

  42. STAT+: MDCalc launches a ‘rumble strip’ for doctors using generative AI tools
    USSTAT News

    MDCalc , a medical reference tool site, on Wednesday launched CrossCover, a tool the company said is meant to help clinicians trust the answers of medical artificial intelligence chatbots while preserving patient and provider privacy…